Abstract:BACKGROUND: Protective CD4+CD25+ regulatory T cells bearing the Forkhead Foxp3 transcription factor can now be divided into three subsets: Endogenous thymus-derived cells, those induced in the periphery, and another subset induced ex-vivo with pharmacological amounts of IL-2 and TGF-β. Unfortunately, endogenous CD4+CD25+ regulatory T cells are unstable and can be converted to effector cells by pro-inflammatory cytokines. Although protective Foxp3+CD4+CD25+ cells resistant to proinflammatory cytokines have been generated in mice, in humans this result has been elusive. Our objective, therefore, was to induce human naïve CD4+ cells to become stable, functional CD25+ Foxp3+ regulatory cells that were also resistant to the inhibitory effects of proinflammatory cytokines. METHODOLOGY/PRINCIPAL FINDINGS: The addition of the vitamin A metabolite, all-trans retinoic acid (atRA) to human naïve CD4+ cells suboptimally activated with IL-2 and TGF-β enhanced and stabilized FOXP3 expression, and accelerated their maturation to protective regulatory T cells. AtRA, by itself, accelerated conversion of naïve to mature cells but did not induce FOXP3 or suppressive activity. The combination of atRA and TGF-β enabled CD4+CD45RA+ cells to express a phenotype and trafficking receptors similar to natural Tregs. AtRA/TGF-β-induced CD4+ regs were anergic and low producers of IL-2. They had potent in vitro suppressive activity and protected immunodeficient mice from a human-anti-mouse GVHD as well as expanded endogenous Tregs. However, treatment of endogenous Tregs with IL-1β and IL-6 decreased FOXP3 expression and diminished their protective effects in vivo while atRA-induced iTregs were resistant to these inhibitory effects. CONCLUSIONS/SIGNIFICANCE: We have developed a methodology that induces human CD4(+) cells to rapidly become stable, fully functional suppressor cells that are also resistant to proinflammatory cytokines. This methodology offers a practical novel strategy to treat human autoimmune diseases and prevent allograft rejection without the use of agents that kill cells or interfere with signaling pathways.

Transforming growth factor‑β2 increases the capacity of retinal pigment epithelial cells to induce the generation of regulatory T cells.

TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses Through a Noncytotoxic Mechanism

Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta

Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels

Protein tyrosine phosphatase 1B regulates the activity of retinal pigment epithelial cells.

The immune privilege of the eye: human retinal pigment epithelial cells selectively modulate T-cell activation in vitro

Engagement of Toll-like Receptor 2 Enhances Interleukin (IL)-17(+) Autoreactive T Cell Responses Via P38 Mitogen-Activated Protein Kinase Signalling in Dendritic Cells.

Retinoic Acid, IL-2 and TGF-β can Rapidly Induce Naïve Human CD4+ Cells to Become CD25+Foxp3+ Regulatory Cells with Protective Activity in vivo

TGF-β2 secretion from RPE decreases with polarization and becomes apically oriented

Regulation of T-lymphocyte CCL3 and CCL4 production by retinal pigment epithelial cells

Bfgf Induced Transdifferentiation of Human Embryonic Retinal Pigment Epithelium Cells

Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation

Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms

The Role of Mechanical Stretch and TGF-β2 in Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells.

Foxp3+ Tregs are recruited to the retina to repair pathological angiogenesis

MiR-302d inhibits TGFB-induced EMT and promotes MET in primary human RPE cells

Characterization of Protective Human CD4CD25 FOXP3 Regulatory T Cells Generated with IL-2, TGF-β and Retinoic Acid.

Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.

Properties of TNFR2, PDL-1 Dependent Human CD8+ Regulatory Cells Generated Ex-Vivo That Can Be Strongly Protective in Vivo (116.4)

Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy

Effects of TGF-β on human embryonic retinal pigment epithelium cells